Researchers map paths to cancer drug resistance

23 diciembre 2014

Key events that prompt certain cancer cells to develop resistance to otherwise lethal therapies have been identified by researchers. By mapping the specific steps that cells of melanoma, breast cancer and a blood cancer called myelofibrosis use to become resistant to drugs, the researchers now have much better targets for blocking those pathways and keeping current therapies effective.